NuSkin Enterprises NUS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.3%-0.1pp | 69.4%+2.2pp | 67.2%0.0pp | 67.2%-0.3pp | 67.6%-0.7pp | |
| Operating margin | 5.5%+1.1pp | 4.4%+5.1pp | -0.7%+0.2pp | -0.9%+9.3pp | -10.1%-1.4pp | |
| Net margin | 3.8%-7.0pp | 10.8%+3.8pp | 7%+0.8pp | 6.2%+8.5pp | -2.3%+6.2pp | |
| EBITDA margin | 9%+1.1pp | 7.9%+5.0pp | 2.9%0.0pp | 2.9%+9.1pp | -6.2%-1.5pp | |
| Free cash flow margin | 2.9%-0.2pp | 3.1%-0.3pp | 3.4%-0.2pp | 3.6%-0.3pp | 3.9%-0.1pp | |
| Returns | ||||||
| Return on equity | 7%-15.0pp | 22%+7.4pp | 14.5%+0.9pp | 13.7%+18.6pp | -4.9%+15.0pp | |
| Return on assets | 3.9%-7.2pp | 11.1%+3.9pp | 7.3%+0.6pp | 6.7%+9.1pp | -2.5%+6.5pp | |
| Return on invested capital | 7.6%+1.7pp | 5.9%+6.9pp | -1%+0.2pp | -1.3%+15.2pp | -16.5%-2.2pp | |
| Efficiency | ||||||
| Asset turnover | 1×0.0× | 1×0.0× | 1×0.0× | 1.1×0.0× | 1.1×0.0× | |
| Inventory turnover | 2.4×-0.1× | 2.5×+0.1× | 2.4×-0.1× | 2.5×+0.1× | 2.4×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2×0.0× | 2.1×-0.1× | 2.2×+0.1× | 2×0.0× | 2×+0.2× | |
| Quick ratio | 1.3×-0.1× | 1.4×-0.1× | 1.5×+0.1× | 1.4×+0.1× | 1.3×+0.1× | |
| Cash ratio | 0.8×-0.1× | 0.9×-0.1× | 1×+0.1× | 0.9×+0.1× | 0.8×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×-0.3× | |
| Debt-to-assets | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×-0.1× | |
| Net debt / EBITDA | 0.8×— | —— | —— | —— | —— | |
| Interest coverage | 5.3×+0.6× | 4.7×+5.4× | -0.7×+0.1× | -0.8×+6.8× | -7.6×-1.9× | |
| Per Share | ||||||
| Book value per share | $16.07+0.4% | $16.01+0.7% | $15.90-0.1% | $15.91+6.2% | $14.98+14.2% | |
| Valuation | ||||||
| Market capitalization | $256.35M-38.2% | $468.98M-22.3% | $603.38M+57.4% | $383.44M+6.2% | $360.99M+5.4% | |
| Enterprise value | $348.19M-25.7% | $538.99M-19.8% | $671.86M+46.5% | $458.46M-6.0% | $487.78M-23.2% | |
| Price / earnings | 4.5×+0.6× | —— | —— | —— | —— | |
| Price / sales | 0.2×-0.1× | 0.3×-0.1× | 0.4×+0.2× | 0.2×0.0× | 0.2×0.0× | |
| Price / book | 0.3×-0.2× | 0.6×-0.2× | 0.8×+0.3× | 0.5×0.0× | 0.5×0.0× | |
| EV / EBITDA | 2.7×-7.3× | —— | —— | —— | —— | |
| EV / sales | 0.2×0.0× | 0.4×-0.1× | 0.4×+0.1× | 0.3×0.0× | 0.3×-0.1× | |
| Free cash flow yield | 17.1%+2.2pp | 9.8%+1.0pp | 8.8%-6.4pp | 15.3%-3.0pp | 18.3%-2.2pp | |
| Earnings yield | 22.4%-3.2pp | 34.2%+16.0pp | 18.2%-8.1pp | 26.3%+37.0pp | -10.7%+32.1pp | |
| Dividend yield | 4.8%+1.8pp | 2.5%+0.5pp | 2%-1.1pp | 3.1%-0.2pp | 3.3%-0.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do NuSkin Enterprises's ratios come from?
- Every ratio is computed from NuSkin Enterprises's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.